A new report from Deutsche Bank makes the case that the selling in health care stocks is way overdone, and the proverbial baby is being tossed out with the bath water.
One positive from the hammering the pharmaceutical stocks have taken is the Merrill Lynch analysts say investors have been given a golden opportunity to buy the top companies at much better prices.
24/7 Wall St. screened the Merrill Lynch health care universe and found four pharmaceutical stocks rated Buy with outstanding short-term and long-term potential.
Earnings season is hitting its stride next week, and the health care sector, the biotech stocks in particular, have been on a roll for the past 12 months.
Generic drug maker Mylan has proposed to acquire rival Perrigo for $205 per share in cash and stock.
Mylan has announced that it will have a 35 million share secondary offering. At Tuesday's closing price of $59.35, the offering would be valued at $2.08 billion.
Friday's top analyst upgrades, downgrades and initiations include Cameron International, Dollar General, Genworth Financial, Groupon, SunPower, Visa and Yahoo.
The following companies were featured in a new Leerink report on understand testing trends for sexually transmitted diseases.
Here are five stocks that Jefferies highlights in its research report that have catalysts that could be important this week.
The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have created such a stir of late.
Add one more to the litany of pharmaceutical company mergers that are being made to avoid U.S. taxes. Mylan's existing business with part of Abbott's generic drug business.
The Department of Defense awarded $10.46 billion in defense contracts Tuesday. The winning defense contractors included included Olin Corp., Boeing, and General Dynamics. The non-defense related companies included Ibis Biosciences, Kellogg, Brown…
These are the top Wall Street analyst upgrades, downgrades and initiations seen on Monday, May 19, 2014. They include Altria, CenturyLink, Micron, GoGo and AT&T.
Shares of Target took a hit of around 3% Monday morning following the resignation/firing of CEO Gregg Steinhafel. The interim CEO and chairman do not seem like serious candidates for the job.
ThinkstockThe intense analysis of quantitative managers may seem like drudgery, but it can turn up absolute gems for investors looking for solid long ideas. In fact, firms like RBC use as much…
